AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 176 filers reported holding AERIE PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.37 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $259,000 | -42.7% | 22,000 | -28.1% | 0.00% | 0.0% |
| Q2 2020 | $452,000 | +9.4% | 30,600 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $413,000 | -44.2% | 30,600 | 0.0% | 0.00% | -50.0% |
| Q4 2019 | $740,000 | +29.4% | 30,600 | +2.9% | 0.00% | 0.0% |
| Q3 2019 | $572,000 | -36.2% | 29,740 | -2.0% | 0.00% | -33.3% |
| Q2 2019 | $897,000 | -28.9% | 30,340 | +14.3% | 0.00% | -40.0% |
| Q1 2019 | $1,261,000 | +344.0% | 26,555 | +532.3% | 0.01% | +400.0% |
| Q2 2018 | $284,000 | +24.6% | 4,200 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $228,000 | +6.0% | 4,200 | +16.7% | 0.00% | 0.0% |
| Q4 2017 | $215,000 | +5.4% | 3,600 | -14.3% | 0.00% | 0.0% |
| Q3 2017 | $204,000 | +7.9% | 4,200 | +16.7% | 0.00% | 0.0% |
| Q2 2017 | $189,000 | +16.0% | 3,600 | -0.0% | 0.00% | 0.0% |
| Q1 2017 | $163,000 | +19.9% | 3,601 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $136,000 | +16.2% | 3,601 | +16.2% | 0.00% | 0.0% |
| Q3 2016 | $117,000 | +85.7% | 3,100 | -13.9% | 0.00% | – |
| Q2 2016 | $63,000 | +270.6% | 3,600 | +157.1% | 0.00% | – |
| Q1 2016 | $17,000 | -29.2% | 1,400 | +40.0% | 0.00% | – |
| Q4 2015 | $24,000 | +4.3% | 1,000 | -23.1% | 0.00% | – |
| Q3 2015 | $23,000 | -63.5% | 1,300 | -35.0% | 0.00% | -100.0% |
| Q1 2015 | $63,000 | – | 2,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 1,464,749 | $98,944,000 | 34.86% |
| Foresite Capital Management III, LLC | 1,708,046 | $115,379,000 | 24.85% |
| Eversept Partners, LP | 226,902 | $15,327,230 | 7.01% |
| SECTORAL ASSET MANAGEMENT INC | 615,870 | $41,602,000 | 4.65% |
| DAFNA Capital Management LLC | 131,770 | $8,901,000 | 4.17% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 68,666 | $4,638,000 | 3.67% |
| Asymmetry Capital Management, L.P. | 49,756 | $3,361,000 | 3.30% |
| PFM Health Sciences, LP | 2,720,218 | $183,751,000 | 2.88% |
| HealthCor Management, L.P. | 1,314,290 | $88,780,000 | 2.82% |
| Boulegeris Investments, Inc. | 66,540 | $4,495,000 | 2.25% |